British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK.
British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at diagnosis NET Patient Foundation in collaboration with Public Health England have undertaken the first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK to identify areas of unmet need with an aim to inform service improvement.
Recent News
Mounjaro® (Tirzepatide) & Neuroendocrine Cancers
We have had a number of enquiries about the use of Mounjaro® (Tirzepatide) and similar medications (e.g. Wegovy®, etc) in individuals with neuroendocrine cancer. Here we provide a summary of information currently available, which we hope will address some of the...
URGENT UPDATE 9TH JULY – Rare Cancers Bill
Update 11th July 2025 Delighted to see Dr Scott Arthur's Rare Cancers Bill pass through third reading in the House of Commons on Friday. This Bill is a crucial step forward for those living with rare and less common cancers. Thank You to everyone who contacted their...
URGENT ACTION NEEDED – CHANGES TO PIP PROPOSED
URGENT ACTION NEEDED The impact of cancer is far more than medical. With it, comes a hidden and often devastating financial burden that many do not see or expect: the ripple effect extending to family members and carers. From travelling to receive the right treatment...